walid elgammal

Prof. walid elgammal

orcid
Al-Azhar University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
WEwalid elgammal
walid elgammal
Hazem ElkadyHazem Elkady
Hazem Elkady
HMHazem. A. Mahdy
Hazem. A. Mahdy
DHDalal Z. Husein
Dalal Z. Husein
AAAisha A. Alsfouk
Aisha A. Alsfouk
Ibrahim. H. EissaIbrahim. H. Eissa
Ibrahim. H. Eissa
This work presents the synthesis and in vitro , and in silico analyses of new thiadiazole derivatives that are designed to mimic the pharmacophoric characteristics of vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors.

Verified
Journal Article
Open access
PDF file
AHAhmed Halawa
Ahmed Halawa
AEAreej A. Eskandrani
Areej A. Eskandrani
WEwalid elgammal
walid elgammal
SHSaber M. Hassan
Saber M. Hassan
،H،ahmed Hassan
،ahmed Hassan
RORawda Okasha
Rawda Okasha
Protein kinases orchestrate diverse cellular functions; however, their dysregulation is linked to metabolic dysfunctions, associated with many diseases, including cancer. Mitogen-Activated Protein (MAP) kinase is a notoriously oncogenic signaling pathway in human malignancies, where the extracellular signal-regulated kinases (ERK1/2) are focal serine/threonine kinases in the MAP kinase module with numerous cytosolic and nuclear mitogenic effector proteins. Subsequently, hampering the ERK kinase activity by small molecule inhibitors is a robust strategy to control the malignancies with aberrant MAP kinase signaling cascades. Consequently, new heterocyclic compounds, containing a sulfonamide moiety, were rationally designed, aided by the molecular docking of the starting reactant 1-(4-((4-methylpiperidin-1-yl)sulfonyl)phenyl)ethan-1-one (3) at the ATP binding pocket of the ERK kinase domain, which was relying on the molecular extension tactic. The identities of the synthesized compounds (4–33) were proven by their spectral data and elemental analysis. The target compounds exhibited pronounced anti-proliferative activities against the MCF-7, HepG-2, and HCT-116 cancerous cell lines with potencies reaching a 2.96 μM for the most active compound (22). Moreover, compounds 5, 9, 10b, 22, and 28 displayed a significant G2/M phase arrest and induction of the apoptosis, which was confirmed by the cell cycle analysis and the flow cytometry. Thus, the molecular extension of a small fragment bounded at the ERK kinase domain is a valid tactic for the rational synthesis of the ERK inhibitors to control various human malignancies.

19 June 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
HMHazem A. Mahdy
Hazem A. Mahdy
Hazem ElkadyHazem Elkady
Hazem Elkady
WEwalid elgammal
walid elgammal
EEEslam B. Elkaeed
Eslam B. Elkaeed
AAAisha Alsfouk
Aisha Alsfouk
IEIbrahim H. Eissa
Ibrahim H. Eissa

4 November 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
Ibrahim. H. EissaIbrahim. H. Eissa
Ibrahim. H. Eissa
WEwalid elgammal
walid elgammal
HMHazem. A. Mahdy
Hazem. A. Mahdy
SZSusi Zara
Susi Zara
Simone CarradoriSimone Carradori
Simone Carradori
Ahmed MetwalyAhmed Metwaly
Ahmed Metwaly
This study aims to investigate the potential of designed 2,3-dihydro-1,3,4-thiadiazole derivatives as anti-proliferative agents targeting VEGFR-2, utilizing a multidimensional approach combining in vitro and in silico analyses.

15 May 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
IEIbrahim H. Eissa
Ibrahim H. Eissa
Hazem ElkadyHazem Elkady
Hazem Elkady
WEwalid elgammal
walid elgammal
HMHazem.A. Mahdy
Hazem.A. Mahdy
EEEslam B. Elkaeed
Eslam B. Elkaeed
Ahmed MetwalyAhmed Metwaly
Ahmed Metwaly

14 May 2024 in Journal of Photochemistry and Photobiology A: Chemistry
Verified
Journal Article
Closed access
AHAhmed Eid Hassan
Ahmed Eid Hassan
SASalwa A.H. Albohy
Salwa A.H. Albohy
AEAhmed Shafek Elzaref
Ahmed Shafek Elzaref
EEEsmail M. El-Fakharany
Esmail M. El-Fakharany
ASAhmed K. Saleh
Ahmed K. Saleh
WEwalid elgammal
walid elgammal